Innovation in medicine makes so many things possible that we would never have dared to think. For over 150 years, Aesculap has not only followed progress in medicine, but actively promotes it - in surgery, orthopedics and interventional vascular medicine. Aesculap has been part of the B. Braun Group since 1976 and is therefore part of a family-run group with over 64,000 employees in 64 countries.
Thinking ahead for medical progress
The patient-oriented linking of the B. Braun Group's broad range of therapies and products enables Aesculap to work with customers to develop total solutions that create additional added value. Aesculap's success is based on a continuous exchange of knowledge with customers and users. Identifying and understanding needs is an important part of developing new technologies and products.
The safety and quality of patient treatment come first. Our customers benefit from our innovative products and solutions, which are characterized by ergonomic, efficient and sustainable properties and are adapted to clinical processes. In this way, we create the prerequisites for data-based therapy approaches and individualized treatment concepts.
B. Braun works in close partnership with customers to develop product systems and solutions that go further and further - and thus protect and improve the health of people all over the world.